Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 5Glioblastoma 4Liver Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Astrocytoma 2Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Temozolomide 3Bevacizumab 3Re-Irradiation 2Nivolumab 2Irinotecan 2Cetuximab 2ribociclib 1pembrolizumab 1lutetium Lu 177 dotatate 1dostarlimab 1dipinacoline glutamate 1dinutuximab 1cemiplimab 1abemaciclib 1Vorinostat 1Vincristine 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Mebendazole 1Maintenance 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluid Therapy 1Eflornithine 1Congresses as Topic 1Carboplatin 1CBLC137 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Diffuse Intrinsic Pontine Glioma × Radiotherapy, Conformal × Clear all
NCT01189266 2021-10-28

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

National Cancer Institute (NCI)

Phase 1/2 Completed
79 enrolled 17 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡